<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03553342</url>
  </required_header>
  <id_info>
    <org_study_id>THYRCOR</org_study_id>
    <nct_id>NCT03553342</nct_id>
  </id_info>
  <brief_title>Efficacy of Oral Corticosteroid Therapy in Recurrent Paralyzes After Thyroidectomy</brief_title>
  <official_title>Efficacy of Oral Corticosteroid Therapy in Recurrent Paralyzes After Thyroidectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Poitiers University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Poitiers University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Thyroidectomy is a common surgical procedure in France. Recurrent paralysis is one of the
      main complications. Oral corticosteroid therapy are frequently used at a dosage of 1mg/kg for
      seven days, in case of recurrent paralysis to obtain remobilization as early as possible.

      The main objective is to evaluate the efficacy of oral corticosteroid therapy in
      remobilization of vocal cords at seven days in patients with unilateral recurrent paralysis
      after thyroidectomy.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 11, 2018</start_date>
  <completion_date type="Anticipated">January 11, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 11, 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate the efficacy of oral corticosteroid in remobilization of vocal cords at seven days for patients with unilateral recurrent laryngeal nerve palsy after thyroidectomy</measure>
    <time_frame>Seven days</time_frame>
    <description>evaluated by naso fibroscope inspection</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">156</enrollment>
  <condition>Recurrent Paralysis of Vocal Cords</condition>
  <arm_group>
    <arm_group_label>Corticoids</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Corticoids</intervention_name>
    <description>Patients will receive corticosteroids therapy: 1mg/kg of prednisolone daily for seven days.</description>
    <arm_group_label>Corticoids</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Patients will receive placebo for seven days.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients scheduled for simple total thyroidectomy or lobo-isthmectomy

          -  Patients over eighteen years old

          -  Free subject, whitout tutorship or curatorship or subordination

          -  Informed consent and signed by the patient after clear and fair information about the
             study.

        Exclusion Criteria:

          -  Patients operated on a total thyroidectomy with médiastino-recurrent dissection for
             cancer etiology

          -  Patients with preoperative recurrent paralysis

          -  Patients with hypersensitivity to prednisolone or any of the excipients.

          -  Patients with contraindication to use Solupred

          -  Patients with anti-inflammatory of acetylsalicylic acid

          -  Patient with evolving virosis (hepatitis, herpes, chicken pox, zoster)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Xavier DUFOUR, Pr</last_name>
    <phone>0549444328</phone>
    <phone_ext>+33</phone_ext>
    <email>xavier.dufour@chu-poitiers.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Véronique DE MONTAUDRY, ARC</last_name>
    <phone>05.49.44.45.12</phone>
    <email>veronique.martin-de-montaudry@chu-poitiers.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Chu Poitiers</name>
      <address>
        <city>Poitiers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xavier DUFOUR, DR</last_name>
      <phone>05.49.44.60.38</phone>
      <email>xavier.dufour@chu-poitiers.fr</email>
    </contact>
    <contact_backup>
      <last_name>Florent CARSUZAA</last_name>
      <email>florent.carsuzaa@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>May 23, 2018</study_first_submitted>
  <study_first_submitted_qc>June 11, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 12, 2018</study_first_posted>
  <last_update_submitted>August 23, 2019</last_update_submitted>
  <last_update_submitted_qc>August 23, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 28, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vocal Cord Paralysis</mesh_term>
    <mesh_term>Paralysis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

